Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Frontiers in Psychology
|
July 11, 2022
Age-Related Differences in Amygdala Activation Associated With Face Trustworthiness but No Evidence of Oxytocin Modulation
Tian Lin, Didem Pehlivanoglu, Maryam Ziaei, et al.
Neurobiology of Aging
|
March 15, 2019
Oxytocin alters patterns of brain activity and amygdalar connectivity by age during dynamic facial emotion identification
Marilyn Horta, Maryam Ziaei, Tian Lin, et al.
Brain Stimulation
|
August 17, 2021
Reply to Tendler et al
Joseph J Taylor, Noam G Newberger, Adam P Stern, et al.
Brain Stimulation
|
June 16, 2021
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions
Joseph J Taylor, Noam G Newberger, Adam P Stern, et al.
General Hospital Psychiatry
|
July 17, 2010
A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients
Kai MacDonald, Michael P Wilson, Arpi Minassian, et al.
The Journal of Clinical Psychiatry
|
April 21, 2004
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam
Glenn W Currier, James C-Y Chou, David Feifel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 27, 2004
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder
Sharon Wigal, James M Swanson, David Feifel, et al.
Journal of Clinical Psychopharmacology
|
May 1, 2012
A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation
Kai MacDonald, Michael Wilson, Arpi Minassian, et al.
The Journal of Clinical Psychiatry
|
February 8, 2011
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
Michael H Allen, David Feifel, Michael D Lesem, et al.
General Hospital Psychiatry
|
November 7, 2009
The Psychiatric Emergency Research Collaboration-01: methods and results
Edwin D Boudreaux, Michael H Allen, Cindy Claassen, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Frontiers in Psychology
|
July 11, 2022
Age-Related Differences in Amygdala Activation Associated With Face Trustworthiness but No Evidence of Oxytocin Modulation
Tian Lin, Didem Pehlivanoglu, Maryam Ziaei, et al.
Neurobiology of Aging
|
March 15, 2019
Oxytocin alters patterns of brain activity and amygdalar connectivity by age during dynamic facial emotion identification
Marilyn Horta, Maryam Ziaei, Tian Lin, et al.
Brain Stimulation
|
August 17, 2021
Reply to Tendler et al
Joseph J Taylor, Noam G Newberger, Adam P Stern, et al.
Brain Stimulation
|
June 16, 2021
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions
Joseph J Taylor, Noam G Newberger, Adam P Stern, et al.
General Hospital Psychiatry
|
July 17, 2010
A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients
Kai MacDonald, Michael P Wilson, Arpi Minassian, et al.
The Journal of Clinical Psychiatry
|
April 21, 2004
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam
Glenn W Currier, James C-Y Chou, David Feifel, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 27, 2004
A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder
Sharon Wigal, James M Swanson, David Feifel, et al.
Journal of Clinical Psychopharmacology
|
May 1, 2012
A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation
Kai MacDonald, Michael Wilson, Arpi Minassian, et al.
The Journal of Clinical Psychiatry
|
February 8, 2011
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial
Michael H Allen, David Feifel, Michael D Lesem, et al.
General Hospital Psychiatry
|
November 7, 2009
The Psychiatric Emergency Research Collaboration-01: methods and results
Edwin D Boudreaux, Michael H Allen, Cindy Claassen, et al.
Page
of 12